An Update on Cardiac Transplantation in the United States Based on an Analysis of the UNOS Registry. 2015

Juhi R Khatiwala, and Matthew J Everly
Terasaki Foundation Laboratory, Los Angeles, CA.

Cardiac transplantation remains a viable option for those with end-stage heart disease. In the last few years, the number of heart transplants has begun to increase slightly. Over the last 27 years, the major reasons for cardiac transplant remain coronary artery disease and dilated cardiomyopathy. Currently, heart transplants have an average lifespan of 10.5 years. The main United Network for Organ Sharing characteristics correlating with poor allograft survival include repeat transplantation, ischemic time, post-transplant dialysis, and age at the time of transplant. Data over the last two decades shows that late graft survival continues to improve slightly. This is primarily a result of a decrease in early graft failure. In heart transplant patients, we still need to find ways to stop late (>1 year post-transplant) graft loss.

UI MeSH Term Description Entries

Related Publications

Juhi R Khatiwala, and Matthew J Everly
January 2008, Clinical transplants,
Juhi R Khatiwala, and Matthew J Everly
January 2009, Clinical transplants,
Juhi R Khatiwala, and Matthew J Everly
January 2006, Clinical transplants,
Juhi R Khatiwala, and Matthew J Everly
January 2011, Clinical transplants,
Juhi R Khatiwala, and Matthew J Everly
January 2010, Clinical transplants,
Juhi R Khatiwala, and Matthew J Everly
January 2014, Clinical transplants,
Juhi R Khatiwala, and Matthew J Everly
April 2024, Hepatology (Baltimore, Md.),
Juhi R Khatiwala, and Matthew J Everly
January 1999, Clinical transplants,
Copied contents to your clipboard!